Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Yana Dekempeneer actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
Onderzoeksoutput
-
Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy
Dewulf, J., Massa, S., Navarro, L., Dekempeneer, Y., Santens, F., Ceuppens, H., Breckpot, K., Van Ginderachter, J. A., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 19 dec 2024, In: Journal of Nanobiotechnology. 22, 1, 13 blz., 763.Onderzoeksoutput: Article › peer review
Open Access1 Citaat (Scopus) -
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting
Poty, S., Ordas, L., Dekempeneer, Y., Parach, A. A., Navarro, L., Santens, F., Dumauthioz, N., Bardiès, M., Lahoutte, T., D'Huyvetter, M. & Pouget, J-P., 1 okt 2024, In: Journal of Nuclear Medicine. 65, 10, blz. 1564-1570 7 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus)3 Downloads (Pure) -
Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor microenvironment
Ertveldt, T., Krasniqi, A., Ceuppens, H., Puttemans, J., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., De Veirman, K., Morgenstern, A., Bruchertseifer, F., Keyaerts, M., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 27 sep 2023.Onderzoeksoutput: Poster
-
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α
Dekempeneer, Y., Massa, S., Santens, F., Navarro, L., Berdal, M., Miranda Lucero, M., Pombo Antunes, A. R., Lahoutte, T., Van Ginderachter, J. A., Devoogdt, N. & D'Huyvetter, M., dec 2023, In: Journal of Nuclear Medicine. 64, 12, blz. 1941-1948 8 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand10 Citaten (Scopus)58 Downloads (Pure) -
Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
Ertveldt, T., Krasniqi, A., Ceuppens, H., Puttemans, J., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., De Veirman, K., Morgenstern, A., Bruchertseifer, F., Keyaerts, M., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 1 mei 2023, In: Journal of Nuclear Medicine. 64, 5, blz. 751-758 8 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand13 Citaten (Scopus)55 Downloads (Pure)
Prijzen
-
INCOVO Price Cancer Research
Dekempeneer, Yana (Recipient), dec 2016
Prijs: Prize (including medals and awards)
-
Junior Travel Grant TAT 2017
Dekempeneer, Yana (Recipient), 30 mrt 2017
Prijs: Prize (including medals and awards)
-
Travel Grant EANM 2017
Dekempeneer, Yana (Recipient), 22 okt 2017
Prijs: Prize (including medals and awards)
-
Travel Grant Research Stay Gothenburg
Dekempeneer, Yana (Recipient), 1 mei 2016
Prijs: Prize (including medals and awards)
Activiteiten
-
2020-70
Matthias D'Huyvetter (Supervisor), Claudia Mebis (Contributor), Marijse Hulsbosch (Contributor) & Yana Dekempeneer (Contributor)
2020Activiteit: Other
-
Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation
Yana Dekempeneer (Speaker)
11 mei 2019Activiteit: Talk or presentation at a conference
-
11th International Symposium on Targeted-Alpha-Therapy
Yana Dekempeneer (Participant)
1 apr 2019 → 5 apr 2019Activiteit: Participation in conference
-
Combining bismuth-213 with Nanobodies: finding the match for Targeted Alpha Radionuclide Therapy
Yana Dekempeneer (Speaker)
1 apr 2019 → 5 apr 2019Activiteit: Talk or presentation at a conference
-
European Molecular Imaging Meeting - EMIM 2018
Carlien Geldof (Organiser) & Yana Dekempeneer (Organiser)
21 mrt 2018Activiteit: Participation in conference
Knipsels
-
-
Q&A: Treating cancer with precisely targeted drugs
3/02/17
1 item van Media-aandacht
Pers / media: !!Research
-
-
Jonge wetenschapster krijgt beurs: Yana onderzoekt of kamelen kanker kunnen helpen bestrijden (Het Nieuwsblad)
28/11/15
1 item van Media-aandacht
Pers / media: !!Research
-
Incovo steunt baanbrekend kankeronderzoek van jonge, Zemstse wetenschapper
14/12/16
1 item van Media-aandacht
Pers / media: !!Research
Scriptie
-
Radiolabeling of nanobodies with Bismuth-213 for Targeted Alpha Therapy
Auteur: Caveliers, V., Rens, L. & Dekempeneer, Y., 5 sep 2019Scriptie/Masterproef: Master's Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Auteur: Dekempeneer, Y., Caveliers, V., D'Huyvetter, M., Cardinaels, T., Cornelissen, B., Flamen, P., Hernot, S., Ballet, S. & Breckpot, K., 2 sep 2020Begeleider: Caveliers, V. (Promotor), D'Huyvetter, M. (Promotor), Cardinaels, T. (Externe persoon) (Co-promotor), Cornelissen, B. (Externe persoon) (Jury), Flamen, P. (Jury), Ballet, S. (Jury), Hernot, S. (Jury) & Breckpot, K. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
Targeted alpha therapy with single-domain antibody fragments, a novel cancer treatment
Auteur: Ballet, S. & Dekempeneer, Y., sep 2020Begeleider: Ballet, S. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
TARGETED ALPHA THERAPY WITH SINGLE-DOMAIN ANTIBODY FRAGMENTS, A NOVEL CANCER TREATMENT
Auteur: Ballet, S. & Dekempeneer, Y., jun 2020Begeleider: Ballet, S. (Jury)
Scriptie/Masterproef: Doctoral Thesis
-
The therapeutic efficacy of bismuth-213 labeled anti-HER2 nanobodies in a preclinical model of ovarian cancer
Auteur: Cantoro, N., Caveliers, V. & Dekempeneer, Y., 12 jun 2020Begeleider: Laoui, D. (Jury) & Caveliers, V. (Promotor)
Scriptie/Masterproef: Master's Thesis